| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $654.7M | +4.6% |
| Cost of Revenue | $484.5M | +0.5% |
| Gross Profit | $170.2M | +18.5% |
| R&D Expense | $13.7M | +10.5% |
| SG&A Expense | $126.7M | +16.9% |
| Operating Income | $43.2M | +23.1% |
| Pre-tax Income | $33.4M | +5.3% |
| Income Tax | $2.6M | -59.5% |
| Net Income | $30.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.6M | +197.0% |
| Inventory | $124.9M | -1.3% |
| Current Assets | $303.7M | +5.9% |
| Total Assets | $415.1M | +7.9% |
| Current Liabilities | $154.1M | +10.4% |
| Long-term Debt | $50.0M | +0.0% |
| Total Liabilities | $249.2M | +4.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $65.4M | -26.2% |
| Capital Expenditures | $3.2M | -6.6% |
| Investing Cash Flow | -$13.9M | -168.3% |
| Financing Cash Flow | -$20.9M | +70.1% |
| Free Cash Flow | $62.2M | -27.0% |
| +21.9% |
| EPS (Basic) | $2.20 | +22.2% |
| EPS (Diluted) | $2.20 | +22.2% |
| Stockholders' Equity |
| $165.9M |
| +12.7% |